CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin®) NSC 683550, IND# 7135]

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00064103
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:22.775946+00:00
Published At: 2013-01-23T00:00:00+00:00
Record Updated At: 2013-01-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lip and Oral Cavity Cancer", "Oropharyngeal Cancer", "Stage 0 Lip and Oral Cavity Cancer", "Stage 0 Oropharyngeal Cancer", "Tongue Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-01-23"
protocolSection.identificationModule.nctId: "NCT00064103"
protocolSection.identificationModule.officialTitle: "Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin\u00ae) NSC 683550, IND# 7135]"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.